Navigation Links
MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
Date:5/27/2009

    Site to Provide Glucotrace (Fluorodeoxyglucose) for Use in Earlier
    Detection of Disease and Therapy Management

OTTAWA and FLEURUS, Belgium, May 28 /PRNewswire-FirstCall/ - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced the opening of a facility in Fleurus, Belgium for the production of Glucotrace (Fluorodeoxyglucose), a radiopharmaceutical used in positron emission tomography (PET) imaging.

PET imaging produces a three-dimensional image, or picture, of functional processes in the body, such as brain activity, and is a highly accurate and effective method of diagnosing disease and managing patient therapy. MDS Nordion's new facility will provide timely supply of Glucotrace to hospitals throughout Belgium, France, The Netherlands, Luxembourg and Germany.

"Customers count on MDS Nordion for leadership, quality products and customized services," said Steve West, President MDS Nordion. "Our investment in this facility further demonstrates our commitment to address the growing demand for PET diagnostic imaging in targeted European regions, and provides the medical community greater service for their future patient care."

The PET imaging market is the most rapidly growing area of nuclear medicine and procedures. Statistics from a recent Medical Options survey indicates PET examinations are on a rapid rise in Europe, and are expected to grow at a compound annual rate of approximately 20% through 2012. To help meet increasing demand, this state-of-the-art, Good Manufacturing Practice (GMP) production facility will have three daily production runs and a customer service team available 24 hours a day, seven days a week.

"PET imaging is effective because it allows early detection of tumours, as well as assessment of therapeutic strategies," said Professor Roland Hustinx, Nuclear Medicine Department, CHU - Universite de Liege. "In particular, MDS Nordion's new facility will provide another source of supply of Glucotrace to existing and new medical facilities, thereby increasing the ability of health-care practitioners to conduct this critical type of imaging."

About MDS Nordion

MDS Nordion, a business unit of MDS Inc., is a global leader in providing medical isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies for medical products that benefit the lives of millions of people in more than 50 countries around the world. MDS Nordion's products and services are used on a daily basis by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Find out more at www.mdsnordion.com.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs, and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,000 highly skilled people in 29 countries. Find out more at www.mdsinc.com.


'/>"/>
SOURCE MDS Nordion
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MDS Nordion signs 17-year contract with Rosenergoatom
2. MDS Nordion Divests Non Strategic Product Lines
3. MDS Nordion Provides Update to Medical Isotope Customers
4. Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation
5. MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians
6. MDS Nordion Provides Update on AECLs Medical Isotope Supply Disruption
7. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
8. An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region
9. Concentra Opens On-Site Medical Unit at World Trade Center Site
10. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... The American Academy of Thermology ... development, healthcare training and clinical application of medical infrared imaging, has announced the ... Qualification Courses for Technicians, respectively. , For the first time the AAT is ...
(Date:1/23/2017)... ... , ... "ProRandom is a set of camera tools that allow video editors to integrate up ... X," said Christina Austin - CEO of Pixel Film Studios. , With ProRandom, video ... footage. ProRandom works by using a virtual camera to create the illusion of a ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Crossing the Bar”: a moving ... a woman’s life. “Crossing the Bar” is the creation of published author, Charlotte Hotte, ... , Charlotte, who credits the inspiration of the book to her sister, Denise, wishes ...
(Date:1/22/2017)... , ... January 22, 2017 , ... Phytocéane invites clients ... from the rest of the world with ZANZIBAR MILKY CREAM. Inspired by the beauty ... ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, velvety ...
(Date:1/21/2017)... Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Germany, announced it is bringing its product to the United States as part of ... over the last 25 years, Alcovit aims to reduce the productions of nasty toxins ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... -- According to a new market research report "Life ... SCM), Component (Software, Service), Delivery (On premise, Cloud), End user (Pharmaceutical, ... the market is expected to reach USD 24.73 Billion by 2021 ... during the forecast period. Continue Reading ... ...
(Date:1/21/2017)... Jan 20, 2017 Research and Markets has ... & Trends - Technology, Route Of Administration, End User - Forecast ... ... poised to grow at a CAGR of around 7.8% over the ... This industry report analyzes the global markets for Advanced Drug ...
(Date:1/20/2017)... 2017 Research and Markets has announced ... Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company ... ... Hearing Aids Market Sales Volume, Company Analysis and Forecast to ... aid industry. The growing prevalence of hearing impairment ...
Breaking Medicine Technology: